About this webinar:
To collect data for a plethora of stakeholders, CMOs can be tempted to design study protocols that increase patient burden, operational foot-print, timelines and cost by adding more measures, biomarkers and endpoints. In this webinar, panelists address how CMOs can develop a balanced strategy that takes into account the ambition to answer questions with the realities of complicated clinical trials. This is a rebroadcast from the 2025 Chief Medical Officer Summit 360°.
More specifically:
Prioritizing data collection strategy to answer key scientific questions while avoiding overcomplication
Designing trials around real patients rather than ideal patients
Better understanding the objectives of the study and asking the questions that achieve those objectives
Better partnering with patients and PIs
Moderators
Panelists
